Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > About Us > Legislation > SROs > SRO 406(I)/2022 (Reduction in MRP of Remdesivir 100mg injection)

SRO 406(I)/2022 (Reduction in MRP of Remdesivir 100mg injection)

Ijaz Mustafa SROs March 10, 2022March 10, 2022

SRO-406-I2022 Download

Share this:

Twitter
Facebook

← Corrigendum(Tender Notice No. F.1-1/2019-(B&A) (Audit) dated 16-02- 2022)
Promotion and Growth of Active Pharmaceutical Ingredient (API) Industry in Pakistan →

DRAP at a Glance
Organization
Legislation
- Acts
- Rules
- Regulations
- SROs
- Notifications
Boards and Committees
Quality Management System
- Quality Policy
- Management Reviews
Contact Us

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem